SCHEMBL23355705

SCHEMBL23355705

CC(C)c1cccc(CNC(=O)O)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.53
ADORA2A P29274 5/20 0.50
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 1/20 0.38
BRD4 O60885 1/20 0.38
POLB P06746 2/20 0.37
TRPV3 Q8NET8 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181434 0.87 NPSR1 (0.72) NPSR1ADORA2ACYP1A2CYP2C9CYP2C19
SCHEMBL13734815 0.83 NPSR1 (0.59) NPSR1ADORA2ACYP1A2CYP2D6TSHR
SCHEMBL28520175 0.80 ADORA2A (0.47) NPSR1ADORA2ACYP1A2POLBMAPK1
SCHEMBL2635459 0.78 NPSR1 (0.53) NPSR1CYP1A2CYP2D6TSHRCYP2C9
SCHEMBL17828026 0.78 ADORA2A (0.43) NPSR1ADORA2ASMN1; SMN2MAPTBRD4
SCHEMBL23015676 0.76 TRPV3 (0.40) NPSR1ADORA2ASMN1; SMN2TRPV3
SCHEMBL3747154 0.76 NPSR1 (0.59) NPSR1ADORA2ACYP1A2CYP2D6TSHR
SCHEMBL20525055 0.75 NPSR1 (0.58) NPSR1ADORA2ACYP1A2CYP2D6TSHR
SCHEMBL21874081 0.75 NPSR1 (0.53) NPSR1ADORA2ACYP1A2CYP2D6TSHR
SCHEMBL20524911 0.75 NPSR1 (0.58) NPSR1ADORA2ACYP1A2CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820474-A1 ADENOSINE RECEPTOR BINDING COMPOUNDS Nikang Therapeutics, Inc. (US) 2021-05-19 EP disclosed